Search Results

5701 - 5725 of 75640
TitleWireDateTime
Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC) Globe Newswire 08/03 07:30
Bombardier to Showcase its Exquisite Challenger 3500 at LABACE 2026 as Part of Extensive Multi-City Latin American Tour Globe Newswire 08/03 07:30
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results Globe Newswire 08/03 07:30
Crescent Biopharma Announces Grants of Inducement Awards Globe Newswire 08/03 07:30
BTU INVESTOR DEADLINE: Peabody Energy Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law Globe Newswire 08/03 07:25
Wine and Champagne Gifts Launches Same-Day Wine and Champagne Delivery in Los Angeles, CA Globe Newswire 08/03 07:15
GRAL DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Globe Newswire 08/03 07:15
Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors Globe Newswire 08/03 07:13
OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor July Payment Volume Increased 107.6% Month Over Month Globe Newswire 08/03 07:09
Avista Corp. Reports Q2 2026 Financial Results, Confirms 2026 Utility Earnings Guidance Globe Newswire 08/03 07:05
X-energy, SGL Carbon Announce Capacity Expansion for Nuclear-Grade Graphite Globe Newswire 08/03 07:01
Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia Globe Newswire 08/03 07:00
TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance Globe Newswire 08/03 07:00
Sportradar Reports Second Quarter 2026 Financial Results Globe Newswire 08/03 07:00
Luckin Coffee Announces Second Quarter 2026 Financial Results Globe Newswire 08/03 07:00
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S. Globe Newswire 08/03 07:00
PPHC Acquires Florida Government Relations Firm Globe Newswire 08/03 07:00
Fervo Energy to Report Second Quarter 2026 Results on August 12, 2026 Globe Newswire 08/03 07:00
Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease Globe Newswire 08/03 07:00
Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results Globe Newswire 08/03 07:00
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights Globe Newswire 08/03 07:00
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System Globe Newswire 08/03 07:00
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome Globe Newswire 08/03 07:00
OutSolve Earns Two-Star Certification from The DaVinci Awards® Globe Newswire 08/03 07:00
BCB Bancorp, Inc. Reports Net Loss of $14.8 Million in the Second Quarter 2026; Board Approves Reincorporation in Delaware, Subject to Shareholder Approval Globe Newswire 08/03 07:00
5701 - 5725 of 75640

News, Photo and Web Search